Kay Haggart

847 total citations
19 papers, 648 citations indexed

About

Kay Haggart is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Kay Haggart has authored 19 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 15 papers in Pulmonary and Respiratory Medicine and 9 papers in Immunology and Allergy. Recurrent topics in Kay Haggart's work include Asthma and respiratory diseases (19 papers), Respiratory and Cough-Related Research (13 papers) and Allergic Rhinitis and Sensitization (9 papers). Kay Haggart is often cited by papers focused on Asthma and respiratory diseases (19 papers), Respiratory and Cough-Related Research (13 papers) and Allergic Rhinitis and Sensitization (9 papers). Kay Haggart collaborates with scholars based in United Kingdom, Australia and United States. Kay Haggart's co-authors include Brian J. Lipworth, Daniel K.C. Lee, Graeme P. Currie, Tom Fardon, Lesley C. McFarlane, Andrew M. Wilson, Sandra D. Anderson, Erika Sims, John D. Brannan and Thomas C. Fardon and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Kay Haggart

18 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kay Haggart United Kingdom 14 536 432 247 49 44 19 648
Daniel K.C. Lee United Kingdom 18 742 1.4× 613 1.4× 239 1.0× 36 0.7× 31 0.7× 39 876
Kristof Raemdonck United Kingdom 11 281 0.5× 214 0.5× 86 0.3× 27 0.6× 19 0.4× 16 506
I.D. Chapman Canada 8 229 0.4× 140 0.3× 44 0.2× 6 0.1× 5 0.1× 13 319
Christine A. McCary United States 8 122 0.2× 54 0.1× 37 0.1× 10 0.2× 9 0.2× 9 367
R. Townley United States 7 275 0.5× 245 0.6× 53 0.2× 6 0.1× 5 0.1× 16 348
A. M. Vermeulen Netherlands 12 72 0.1× 27 0.1× 210 0.9× 119 2.4× 7 0.2× 24 358
Sümeyye Alparslan Bekir Türkiye 5 248 0.5× 223 0.5× 54 0.2× 3 0.1× 8 0.2× 14 352
Martina Antošová Slovakia 12 125 0.2× 146 0.3× 35 0.1× 2 0.0× 8 0.2× 34 352
Piers Dixey United Kingdom 3 115 0.2× 65 0.2× 15 0.1× 4 0.1× 11 0.3× 4 237
Larry Gontovnick Canada 8 265 0.5× 216 0.5× 38 0.2× 4 0.1× 3 0.1× 14 360

Countries citing papers authored by Kay Haggart

Since Specialization
Citations

This map shows the geographic impact of Kay Haggart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Haggart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Haggart more than expected).

Fields of papers citing papers by Kay Haggart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay Haggart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Haggart. The network helps show where Kay Haggart may publish in the future.

Co-authorship network of co-authors of Kay Haggart

This figure shows the co-authorship network connecting the top 25 collaborators of Kay Haggart. A scholar is included among the top collaborators of Kay Haggart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay Haggart. Kay Haggart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Fardon, Tom, Daniel K.C. Lee, Kay Haggart, et al.. (2007). Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate. British Journal of Clinical Pharmacology. 64(5). 698–705. 13 indexed citations
2.
Fardon, Tom, Kay Haggart, Daniel K.C. Lee, & Brian J. Lipworth. (2006). A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respiratory Medicine. 101(6). 1218–1228. 68 indexed citations
3.
Lee, Daniel K.C., et al.. (2005). Airway and Systemic Effects of Hydrofluoroalkane Formulations of High-Dose Ciclesonide and Fluticasone in Moderate Persistent Asthma. CHEST Journal. 127(3). 851–860. 57 indexed citations
4.
Fardon, Tom, Daniel K.C. Lee, Kay Haggart, Lesley C. McFarlane, & Brian J. Lipworth. (2004). Adrenal Suppression with Dry Powder Formulations of Fluticasone Propionate and Mometasone Furoate. American Journal of Respiratory and Critical Care Medicine. 170(9). 960–966. 63 indexed citations
5.
Lee, Daniel K.C., Catherine Jackson, Kay Haggart, & Brian J. Lipworth. (2004). Repeated Dosing Effects of Mediator Antagonists in Inhaled Corticosteroid-Treated Atopic Asthmatic Patients. CHEST Journal. 125(4). 1372–1377. 16 indexed citations
6.
Haggart, Kay, et al.. (2004). Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma. European Respiratory Journal. 24(2). 226–230. 21 indexed citations
7.
Lee, Daniel K.C., Kay Haggart, & Brian J. Lipworth. (2004). Reproducibility of response to nasal lysine-aspirin challenge in patients with aspirin-induced asthma. Annals of Allergy Asthma & Immunology. 93(2). 185–188. 13 indexed citations
8.
Gardiner, Michael, et al.. (2004). Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis. Clinical & Experimental Allergy. 34(4). 650–653. 36 indexed citations
9.
Gray, Robert D., et al.. (2004). Effects of butterbur treatment in intermittent allergic rhinitis: a placebo-controlled evaluation. Annals of Allergy Asthma & Immunology. 93(1). 56–60. 32 indexed citations
10.
11.
Haggart, Kay, et al.. (2004). Butterbur, a herbal remedy, confers complementary anti‐inflammatory activity in asthmatic patients receiving inhaled corticosteroids. Clinical & Experimental Allergy. 34(1). 110–114. 20 indexed citations
12.
Haggart, Kay, et al.. (2004). Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma. Journal of Allergy and Clinical Immunology. 113(2). S35–S35. 1 indexed citations
13.
Currie, Graeme P., et al.. (2003). Effects of Montelukast on Surrogate Inflammatory Markers in Corticosteroid-treated Patients with Asthma. American Journal of Respiratory and Critical Care Medicine. 167(9). 1232–1238. 89 indexed citations
14.
Currie, Graeme P., et al.. (2003). Relationship between airway hyperresponsiveness to mannitol and adenosine monophosphate. Allergy. 58(8). 762–766. 34 indexed citations
15.
Haggart, Kay, et al.. (2003). Butterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis. Clinical & Experimental Allergy. 33(7). 882–886. 37 indexed citations
16.
Lee, Daniel K.C., Kay Haggart, Graeme P. Currie, Sandra D. Anderson, & Brian J. Lipworth. (2003). The effects of histamine and leukotriene receptor antagonism on nasal mannitol challenge in allergic rhinitis. British Journal of Clinical Pharmacology. 55(6). 639–642. 10 indexed citations
17.
Currie, Graeme P., Kay Haggart, Stephen J. Fowler, et al.. (2003). Effects of mediator antagonism on mannitol and adenosine monophosphate challenges. Clinical & Experimental Allergy. 33(6). 783–788. 47 indexed citations
18.
Currie, Graeme P., et al.. (2003). Montelukast confers complimentary non-steroidal anti-inflammatory activity in asthmatics receiving fluticasone alone and fluticasone/salmeterol combination. Journal of Allergy and Clinical Immunology. 111(2). S146–S146. 4 indexed citations
19.
Wilson, Andrew M., Kay Haggart, Erika Sims, & Brian J. Lipworth. (2002). Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. Clinical & Experimental Allergy. 32(10). 1504–1509. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel K.C. Lee Breakdown of academic impact, for papers by Kristof Raemdonck Breakdown of academic impact, for papers by I.D. Chapman Breakdown of academic impact, for papers by Christine A. McCary Breakdown of academic impact, for papers by R. Townley Breakdown of academic impact, for papers by A. M. Vermeulen Breakdown of academic impact, for papers by Sümeyye Alparslan Bekir Breakdown of academic impact, for papers by Martina Antošová Breakdown of academic impact, for papers by Piers Dixey Breakdown of academic impact, for papers by Larry Gontovnick
Rankless by CCL
2026